These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 16857545)

  • 1. Depot medroxyprogesterone acetate and bone mineral density in adolescents--the Black Box Warning: a Position Paper of the Society for Adolescent Medicine.
    Cromer BA; Scholes D; Berenson A; Cundy T; Clark MK; Kaunitz AM;
    J Adolesc Health; 2006 Aug; 39(2):296-301. PubMed ID: 16857545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depo-Provera and skeletal health: a survey of Florida obstetrics and gynecologist physicians.
    Paschall S; Kaunitz AM
    Contraception; 2008 Nov; 78(5):370-6. PubMed ID: 18929733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of depot-medroxyprogesterone acetate in contraception and its potential impact on skeletal health.
    Guilbert ER; Brown JP; Kaunitz AM; Wagner MS; Bérubé J; Charbonneau L; Francoeur D; Gilbert A; Gilbert F; Roy G; Senikas V; Jacob R; Morin R
    Contraception; 2009 Mar; 79(3):167-77. PubMed ID: 19185668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depot medroxyprogesterone acetate: implications for weight status and bone mineral density in the adolescent female.
    Bonny AE; Harkness LS; Cromer BA
    Adolesc Med Clin; 2005 Oct; 16(3):569-84. PubMed ID: 16183540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Injectable depot medroxyprogesterone acetate contraception: an update for U.S. clinicians.
    Kaunitz AM
    Int J Fertil Womens Med; 1998; 43(2):73-83. PubMed ID: 9609206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Injectable contraception.
    Roy G
    Semin Reprod Med; 2010 Mar; 28(2):126-32. PubMed ID: 20352562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone mineral density and DMPA.
    Westhoff C
    J Reprod Med; 2002 Sep; 47(9 Suppl):795-9. PubMed ID: 12380409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-acting contraceptives in adolescents.
    Tolaymat LL; Kaunitz AM
    Curr Opin Obstet Gynecol; 2007 Oct; 19(5):453-60. PubMed ID: 17885461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral density and depot medroxyprogesterone acetate.
    Albertazzi P; Bottazzi M; Steel SA
    Contraception; 2006 Jun; 73(6):577-83. PubMed ID: 16730487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Committee Opinion No. 602: Depot medroxyprogesterone acetate and bone effects.
    Obstet Gynecol; 2014 Jun; 123(6):1398-1402. PubMed ID: 24848921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents: what is next after the FDA black box warning.
    Omar H; Kives S
    J Pediatr Adolesc Gynecol; 2005 Jun; 18(3):183. PubMed ID: 15970252
    [No Abstract]   [Full Text] [Related]  

  • 12. Counseling issues and management of side effects for women using depot medroxyprogesterone acetate contraception.
    Nelson AL
    J Reprod Med; 1996 May; 41(5 Suppl):391-400. PubMed ID: 8725701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decline in bone mineral density with stress fractures in a woman on depot medroxyprogesterone acetate. A case report.
    Harkins GJ; Davis GD; Dettori J; Hibbert ML; Hoyt RA
    J Reprod Med; 1999 Mar; 44(3):309-12. PubMed ID: 10202754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biopsychosocial variables associated with substantial bone mineral density loss during the use of depot medroxyprogesterone acetate in adolescents: adolescents who lost 5% or more from baseline vs. those who lost less than 5%.
    Harel Z; Wolter K; Gold MA; Cromer B; Stager M; Johnson CC; Brown R; Bruner A; Coupey S; Hertweck P; Bone H; Burkman R; Nelson A; Marshall S; Bachrach LK
    Contraception; 2010 Dec; 82(6):503-12. PubMed ID: 21074012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density.
    Kaunitz AM; Darney PD; Ross D; Wolter KD; Speroff L
    Contraception; 2009 Jul; 80(1):7-17. PubMed ID: 19501210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections.
    Harel Z; Johnson CC; Gold MA; Cromer B; Peterson E; Burkman R; Stager M; Brown R; Bruner A; Coupey S; Hertweck P; Bone H; Wolter K; Nelson A; Marshall S; Bachrach LK
    Contraception; 2010 Apr; 81(4):281-91. PubMed ID: 20227543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between depot medroxyprogesterone acetate contraception and bone mineral density in adolescent women.
    Scholes D; LaCroix AZ; Ichikawa LE; Barlow WE; Ott SM
    Contraception; 2004 Feb; 69(2):99-104. PubMed ID: 14759613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral density in women using depot medroxyprogesterone acetate (DMPA) for at least 2 years compared to a control group: a cross sectional study.
    Pongsatha S; Ekmahachai M; Chaovisitsaree S; Suntornlimsiri N; Morakote N
    J Med Assoc Thai; 2009 Oct; 92(10):1263-7. PubMed ID: 19845231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Black box' warning added to contraceptive injection.
    FDA Consum; 2005; 39(2):3. PubMed ID: 16124078
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate.
    Clark MK; Sowers MR; Nichols S; Levy B
    Fertil Steril; 2004 Dec; 82(6):1580-6. PubMed ID: 15589863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.